A post-hoc analysis from the XINDI study 24 indicated that female patients receiving treatment with safinamide showed better therapeutic outcomes compared to males, although these differences did not reach statistical significance.
← all excerpts
Comparing the efficacy and safety of safinamide with rasagiline in China Parkinson's disease patients with a matching adjusted indirect comparison.
1
—
—